Background The lack of an accurate blood biomarker in neuroendocrine tumor (NET)
disease has hindered management. The advance of genomic medicine and the …

Neuroendocrine neoplasms (NENs), also called neuroendocrine tumors (NETs), and
generically referred to as “carcinoids,” represent a spectrum of tumors with a diverse range …

Contrast-enhanced computed tomography (CT) of the neck-thorax-abdomen and pelvis,
including 3-phase examination of the liver, constitutes the basic imaging for primary …

Context: Early and precise delineation of therapeutic responses are key issues in
neuroendocrine neoplasm/tumor management. Imaging is currently used but exhibits …

Continuous progress in the diagnostics and treatment of neuroendocrine neoplasms
(NENs), the emerging results of new clinical trials, and the new guidelines issued by medical …

Background/Aims: A key issue in gastroenteropancreatic neuroendocrine tumors (GEP-
NETs) is early identification and prediction of disease progression. Clinical evaluation and …

Pancreatic neuroendocrine tumors (PanNENs) are rare sporadic cancers or develop as part
of hereditary syndromes. PanNENs can be both functioning and non-functioning based on …

Diagnostic imaging plays a pivotal role in the diagnosis, staging, treatment selection and
follow-up for neuroendocrine tumors. The available diagnostic strategies are morphologic …

Progress in the diagnostics and therapy of gastro-entero-pancreatic (GEP) neuroendocrine
neoplasms (NEN), the published results of new randomised clinical trials, and the new …

Purpose Temozolomide (TEM) based therapy has been reported being effective in the
treatment of metastatic neuroendocrine neoplasms (NEN), with response rates ranging from …